切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (06) : 601 -606. doi: 10.3877/cma.j.issn.2095-3232.2022.06.014

临床研究

加速康复外科理念指导腹腔镜肝巨大血管瘤剥除术疗效
张树彬1, 周新博1, 胡子轩1, 邢中强1, 刘建华1,()   
  1. 1. 050000 石家庄,河北医科大学第二医院肝胆外科
  • 收稿日期:2022-08-30 出版日期:2022-12-10
  • 通信作者: 刘建华

Clinical efficacy of ERAS concept-guided laparoscopic resection of giant liver hemangioma

Shubin Zhang1, Xinbo Zhou1, Zixuan Hu1, Zhongqiang Xing1, Jianhua Liu1,()   

  1. 1. Department of Hepatobiliary Surgery, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Received:2022-08-30 Published:2022-12-10
  • Corresponding author: Jianhua Liu
引用本文:

张树彬, 周新博, 胡子轩, 邢中强, 刘建华. 加速康复外科理念指导腹腔镜肝巨大血管瘤剥除术疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 601-606.

Shubin Zhang, Xinbo Zhou, Zixuan Hu, Zhongqiang Xing, Jianhua Liu. Clinical efficacy of ERAS concept-guided laparoscopic resection of giant liver hemangioma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(06): 601-606.

目的

探讨加速康复外科(ERAS)理念指导下腹腔镜肝巨大血管瘤剥除术的安全性和疗效。

方法

回顾性分析2015年11月至2021年10月河北医科大学第二医院在ERAS理念指导下行腹腔镜肝巨大血管瘤剥除术的45例患者临床资料。其中男23例,女22例;平均年龄(57±10)岁;肝血管瘤直径(13.1±2.3)cm。Ⅰc型11例,Ⅱb型28例,Ⅱc型6例。患者均签署知情同意书,符合医学伦理学规定。围手术期采用ERAS措施促进患者康复,观察患者围手术期情况。

结果

患者均顺利完成手术,无中转开腹,无发生术后出血、胆漏等严重并发症,无围手术期死亡。手术时间(162±45)min;45例均采用第一肝门阻断,阻断时间(32±5)min;术中出血量中位数280(200,353)ml;术中输血11例,最多者输注悬浮红细胞4 U。胃管、腹腔引流管均在术后1 d拔除;首次肛门排气时间(1.1±0.3)d;术后1 d视觉模拟评分法疼痛评分(2.8±0.7)分;术后住院时间(5.3±0.5)d;住院费用(4.6±0.4)万元;肝功能指标均于术后5~10 d恢复正常。随访期间均未见血管瘤复发。

结论

ERAS理念指导下腹腔镜肝巨大血管瘤剥除术安全、可行,具有手术创伤小、恢复速度快等优势。

Objective

To evaluate the safety and efficacy of laparoscopic resection for giant liver hemangioma guided by the concept of enhanced recovery after surgery (ERAS).

Methods

Clinical data of 45 patients who underwent ERAS concept-guided laparoscopic resection of giant liver hemangioma in the Second Hospital of Hebei Medical University from November 2015 to October 2021 were retrospectively analyzed. Among them, 23 patients were male and 22 female, aged (57±10) years on average. The diameter of liver hemangioma was (13.1±2.3) cm. 11 patients were classified as type Ⅰc, 28 cases of type Ⅱb and 6 cases of type Ⅱc. The informed consents of all patients were obtained and the local ethical committee approval was received. Perioperatively, ERAS protocol was adopted to promote the recovery of patients, and perioperative conditions of patients were observed.

Results

All patients successfully completed the surgery without conversion to open surgery. No postoperative bleeding, bile leakage or other severe complications occurred. No perioperative death was observed. The operation time was (162±45) min. 45 patients received occlusion of the porta hepatis and the occlusion time was (32±5) min. The median intraoperative blood loss was280 (200, 353) ml. Intraoperative blood transfusion was performed in 11 cases, and the the largest transfusion amount was 4 U suspended red blood cells. The gastric and abdominal drainage catheters were removed at postoperative 1 d. The first anal exhaust time was (1.1±0.3) d. At postoperative 1 d, the visual analogue scale (VAS) pain score was 2.8±0.7. The length of postoperative hospital stay was (5.3±0.5) d. The hospitalization expense was (4.6±0.4)×104 yuan. Liver function indexes were restored to normal at postoperative 5-10 d. No recurrence of hemangioma was found during the postoperative follow-up.

Conclusions

ERAS concept-guided laparoscopic resection of giant liver hemangioma is safe and feasible, which yields slight trauma and accelerates postoperative recovery.

图1 一例肝多发血管瘤剥除术患者术中图片注:a为肝巨大血管瘤全貌,左肝内叶内血管瘤大小为11 cm×8 cm×8 cm,左肝外叶内为4 cm×3 cm×3 cm,肝尾状叶内为4 cm×3 cm×3 cm;b为预置肝门阻断带;c~h为血管瘤剥除、创面止血、结扎瘤体滋养血管;i为完整剥除标本后装入标本袋
[1]
朱迎哲, 王继涛. 超声刀与钳夹法在巨大肝血管瘤手术应用效果的比较[J]. 肝胆外科杂志, 2020, 28(5):360-363.
[2]
国际肝胆胰协会中国分会肝血管瘤专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8):1928-1931.
[3]
郑学华, 张阳光, 曾禹, 等. 两种术式治疗肝巨大血管瘤临床疗效比较[J]. 实用肝脏病杂志, 2018, 21(6):959-962.
[4]
马亮亮, 邵志江, 李灿明, 等. 肝血管瘤的治疗进展[J]. 黑龙江医学, 2020, 44(5):718-720.
[5]
Xie QS, Chen ZX, Zhao YJ, et al. Outcomes of surgery for giant hepatic hemangioma[J]. BMC Surg, 2021, 21(1):186.
[6]
Sun YM, Wang Y, Mao YX, et al. The safety and feasibility of enhanced recovery after surgery in patients undergoing pancreaticoduodenectomy: an updated meta-analysis[J]. Biomed Res Int, 2020:7401276.
[7]
李秋生,邢中强,冯峰,等.腹腔镜Pringle法肝门阻断下肝血管瘤剥除术221例临床分析[J].中华肝胆外科杂志2018, 24(9): 633-635.
[8]
张树彬, 王丽丽, 冯峰, 等. 腹腔镜肝血管瘤剥除术的临床应用[J]. 腹部外科, 2020, 33(2):136-149.
[9]
夏锋, 李雪松. 肝血管瘤诊断和治疗多学科专家共识(2019版)[J]. 中国实用外科杂志, 2019, 39(8):761-765.
[10]
蔡荣耀, 尹新民, 姚立波, 等. 腹腔镜手术治疗肝脏巨大血管瘤疗效分析[J]. 腹部外科, 2019, 32(6):417-420.
[11]
张秋华, 杨玉玲, 李静, 等. 肝血管瘤剥除术治疗肝血管瘤的疗效及生存质量研究[J]. 北华大学学报(自然科学版), 2019, 20(2): 213-216.
[12]
Marrero JA, Ahn J, Rajender Reddy K, et al. ACG clinical guideline: the diagnosis and management of focal liver lesions[J]. Am J Gastroenterol, 2014, 109(9):1328-1347.
[13]
张津玮, 秦建民. 肝血管瘤治疗指征与处理策略[J]. 肝胆外科杂志, 2020, 28(4):317-320.
[14]
宋京海,贺修文.肝血管瘤剥离术[J/CD].中华普通外科学文献(电子版), 2021, 15(3):202.
[15]
de-Aguilar-Nascimento JE, Salomão AB, Waitzberg DL, et al. ACERTO guidelines of perioperative nutritional interventions in elective general surgery[J]. Rev Col Bras Cir, 2017, 44(6):633-648.
[16]
陈焕伟, 雷秋成. 加速康复外科在肝切除围手术期中的应用现状及经验介绍[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 8(2): 96-100.
[17]
中华医学会外科学分会外科手术学学组, 中国医疗保健国际交流促进会加速康复外科学分会肝脏外科学组. 肝切除术后加速康复中国专家共识(2017版)[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 6(4):254-260.
[18]
杨华, 余金艳. 肝血管瘤切除术后常见并发症及其相关危险因素[J]. 血栓与止血学, 2020, 26(5):876-878.
[19]
中国加速康复外科专家组. 中国加速康复外科围手术期管理专家共识(2016)[J]. 中华外科杂志, 2016, 54(6):413-418.
[20]
刘洁, 林雪琴, 罗芬. 肝切除术患者不置胃管行胃肠减压并早期进食的可行性研究[J].基层医学论坛, 2018, 22(6):725-726.
[21]
谢伟选, 方征, 刘洪, 等. 加速康复外科理念在腹腔镜精准肝切除术治疗肝血管瘤中的临床应用[J]. 中国普通外科杂志, 2019, 28(7):864-870.
[22]
Long DR, Lihn AL, Friedrich S, et al. Association between intraoperative opioid administration and 30-day readmission: apre-specified analysis of registry data from a healthcare network in New England[J]. Br J Anaesth, 2018, 120(5):1090-1102.
[23]
汪一, 韩显林, 陈伟, 等. 不同麻醉与多模式镇痛方案在开腹胰十二指肠切除术加速康复外科中的应用[J]. 协和医学杂志, 2018, 9(6):539-545.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[11] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[12] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?